Limits...
Biological effects of eukaryotic recombinant plasmid pReceiver-M61-BAI-1 transfection on T24 cells and HUVECs.

Tian DW, Hu HL, Sun Y, Tang Y, Lei MD, Liu LW, Han RF, Wu CL - Mol Med Rep (2016)

Bottom Line: The results of the MTT assay demonstrated that absorbance was markedly reduced in HUVECs at 12, 48 and 72 h subsequent to transfection with pReceiver-M61-BAI-1 when compared with that of the control group and in T24 cells transfected with p‑Receiver-M61-BAI-1.Furthermore, flow cytometry results also indicated that the apoptotic rate of HUVECs transfected with p‑Receiver‑M61‑BAI‑1 was significantly increased compared with that of the control group and T24 cells transfected with p‑Receiver‑M61‑BAI‑1.In conclusion, BAI-1 is suggested to be a potential novel therapautic target for the inhibition of tumor neovascularization.

View Article: PubMed Central - PubMed

Affiliation: Department of Urinary Surgery, Tianjin Key Laboratory of Urology, Tianjin Institute of Urology, The Second Hospital of Tianjin Medical University, Tianjin 300211, P.R. China.

ABSTRACT
The aim of the current study was to investigate the biological effect on T24 cells and human umbilical vein endothelial cells (HUVECs) of transfection with brain-specific angiogenesis inhibitor-1 (BAI-1). The recombinant plasmid pReceiver-M61-BAI-1 was transfected into human superficial bladder tumor cells (T24) and HUVECs, in parallel with the vector control. mRNA and protein expression levels of BAI‑1 were then detected by quantitative polymerase chain reaction (qPCR) and western blotting, respectively. Cell apoptosis of T24 cells and HUVECs prior and subsequent to transfection with BAI‑1 was analyzed by flow cytometric analysis. Proliferation of T24 cells and HUVECs prior and subsequent to transfection of BAI-1 was assessed by the MTT method. T24 cells and HUVECs transfected with pReceiver‑M61‑BA1‑1 were classed as the experimental group; T24 cells and HUVECs transfected with p‑Receiver‑M61 were the control group. qPCR and western blotting methods confirmed that there was positive expression of BAI‑1 in T24 cells and HUVECs transfected with pReceiver‑M61‑BAI‑1, however BAI‑1 was not expressed in T24 cells and HUVECs transfected with pReceiver‑M61. The results of the MTT assay demonstrated that absorbance was markedly reduced in HUVECs at 12, 48 and 72 h subsequent to transfection with pReceiver-M61-BAI-1 when compared with that of the control group and in T24 cells transfected with p‑Receiver-M61-BAI-1. Furthermore, flow cytometry results also indicated that the apoptotic rate of HUVECs transfected with p‑Receiver‑M61‑BAI‑1 was significantly increased compared with that of the control group and T24 cells transfected with p‑Receiver‑M61‑BAI‑1. BAI‑1 was observed to markedly inhibit the proliferation of vascular endothelial cells in vitro, however, no direct inhibition by BAI‑1 was observed in T24 cells. In conclusion, BAI-1 is suggested to be a potential novel therapautic target for the inhibition of tumor neovascularization.

No MeSH data available.


Related in: MedlinePlus

Quantitative polymerase chain reaction analysis of (A) HUVEC-BAI-1 and (B) T24-BAI-1 cells. HUVEC, human umbilical vein endothelial cell; BAI-1, brain-specific angiogenesis inhibitor-1; CTR, control plasmid; GAPDH, internal control, glyceraldehyde 3-phosphate dehydrogenase; RFU, relative fluorescence units.
© Copyright Policy - open-access
Related In: Results  -  Collection

License
getmorefigures.php?uid=PMC4940095&req=5

f3-mmr-14-02-1553: Quantitative polymerase chain reaction analysis of (A) HUVEC-BAI-1 and (B) T24-BAI-1 cells. HUVEC, human umbilical vein endothelial cell; BAI-1, brain-specific angiogenesis inhibitor-1; CTR, control plasmid; GAPDH, internal control, glyceraldehyde 3-phosphate dehydrogenase; RFU, relative fluorescence units.

Mentions: Plasmids were identified to have been successfully transfected through the detection of the gene expression of BAI-1 in T24 cells and HUVECs subsequent to transfection with pReceiver-M61-BAI-1 (Fig. 3).


Biological effects of eukaryotic recombinant plasmid pReceiver-M61-BAI-1 transfection on T24 cells and HUVECs.

Tian DW, Hu HL, Sun Y, Tang Y, Lei MD, Liu LW, Han RF, Wu CL - Mol Med Rep (2016)

Quantitative polymerase chain reaction analysis of (A) HUVEC-BAI-1 and (B) T24-BAI-1 cells. HUVEC, human umbilical vein endothelial cell; BAI-1, brain-specific angiogenesis inhibitor-1; CTR, control plasmid; GAPDH, internal control, glyceraldehyde 3-phosphate dehydrogenase; RFU, relative fluorescence units.
© Copyright Policy - open-access
Related In: Results  -  Collection

License
Show All Figures
getmorefigures.php?uid=PMC4940095&req=5

f3-mmr-14-02-1553: Quantitative polymerase chain reaction analysis of (A) HUVEC-BAI-1 and (B) T24-BAI-1 cells. HUVEC, human umbilical vein endothelial cell; BAI-1, brain-specific angiogenesis inhibitor-1; CTR, control plasmid; GAPDH, internal control, glyceraldehyde 3-phosphate dehydrogenase; RFU, relative fluorescence units.
Mentions: Plasmids were identified to have been successfully transfected through the detection of the gene expression of BAI-1 in T24 cells and HUVECs subsequent to transfection with pReceiver-M61-BAI-1 (Fig. 3).

Bottom Line: The results of the MTT assay demonstrated that absorbance was markedly reduced in HUVECs at 12, 48 and 72 h subsequent to transfection with pReceiver-M61-BAI-1 when compared with that of the control group and in T24 cells transfected with p‑Receiver-M61-BAI-1.Furthermore, flow cytometry results also indicated that the apoptotic rate of HUVECs transfected with p‑Receiver‑M61‑BAI‑1 was significantly increased compared with that of the control group and T24 cells transfected with p‑Receiver‑M61‑BAI‑1.In conclusion, BAI-1 is suggested to be a potential novel therapautic target for the inhibition of tumor neovascularization.

View Article: PubMed Central - PubMed

Affiliation: Department of Urinary Surgery, Tianjin Key Laboratory of Urology, Tianjin Institute of Urology, The Second Hospital of Tianjin Medical University, Tianjin 300211, P.R. China.

ABSTRACT
The aim of the current study was to investigate the biological effect on T24 cells and human umbilical vein endothelial cells (HUVECs) of transfection with brain-specific angiogenesis inhibitor-1 (BAI-1). The recombinant plasmid pReceiver-M61-BAI-1 was transfected into human superficial bladder tumor cells (T24) and HUVECs, in parallel with the vector control. mRNA and protein expression levels of BAI‑1 were then detected by quantitative polymerase chain reaction (qPCR) and western blotting, respectively. Cell apoptosis of T24 cells and HUVECs prior and subsequent to transfection with BAI‑1 was analyzed by flow cytometric analysis. Proliferation of T24 cells and HUVECs prior and subsequent to transfection of BAI-1 was assessed by the MTT method. T24 cells and HUVECs transfected with pReceiver‑M61‑BA1‑1 were classed as the experimental group; T24 cells and HUVECs transfected with p‑Receiver‑M61 were the control group. qPCR and western blotting methods confirmed that there was positive expression of BAI‑1 in T24 cells and HUVECs transfected with pReceiver‑M61‑BAI‑1, however BAI‑1 was not expressed in T24 cells and HUVECs transfected with pReceiver‑M61. The results of the MTT assay demonstrated that absorbance was markedly reduced in HUVECs at 12, 48 and 72 h subsequent to transfection with pReceiver-M61-BAI-1 when compared with that of the control group and in T24 cells transfected with p‑Receiver-M61-BAI-1. Furthermore, flow cytometry results also indicated that the apoptotic rate of HUVECs transfected with p‑Receiver‑M61‑BAI‑1 was significantly increased compared with that of the control group and T24 cells transfected with p‑Receiver‑M61‑BAI‑1. BAI‑1 was observed to markedly inhibit the proliferation of vascular endothelial cells in vitro, however, no direct inhibition by BAI‑1 was observed in T24 cells. In conclusion, BAI-1 is suggested to be a potential novel therapautic target for the inhibition of tumor neovascularization.

No MeSH data available.


Related in: MedlinePlus